Page last updated: 2024-08-23

plicamycin and vorinostat

plicamycin has been researched along with vorinostat in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becker, JC; Fan, K; Nghiem, P; Paulson, KG; Ritter, C; Schrama, D1

Other Studies

1 other study(ies) available for plicamycin and vorinostat

ArticleYear
Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma.
    Scientific reports, 2016, Feb-23, Volume: 6

    Topics: Acetylation; Animals; Carcinoma, Merkel Cell; Cell Line, Tumor; Cytotoxicity, Immunologic; Gene Silencing; Histocompatibility Antigens Class I; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Killer Cells, Lymphokine-Activated; Mice; Mice, Inbred NOD; NK Cell Lectin-Like Receptor Subfamily K; Plicamycin; Promoter Regions, Genetic; Signal Transduction; Skin Neoplasms; Vorinostat; Xenograft Model Antitumor Assays

2016